Michael W. Bishop

3.0k total citations
59 papers, 1.1k citations indexed

About

Michael W. Bishop is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael W. Bishop has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael W. Bishop's work include Sarcoma Diagnosis and Treatment (21 papers), Childhood Cancer Survivors' Quality of Life (12 papers) and Neuroblastoma Research and Treatments (9 papers). Michael W. Bishop is often cited by papers focused on Sarcoma Diagnosis and Treatment (21 papers), Childhood Cancer Survivors' Quality of Life (12 papers) and Neuroblastoma Research and Treatments (9 papers). Michael W. Bishop collaborates with scholars based in United States, United Kingdom and Singapore. Michael W. Bishop's co-authors include Richard Görlick, Katherine A. Janeway, J. Chatt, Jonathan R. Dilworth, Alberto S. Pappo, Andrew M. Davidoff, Jianrong Wu, Kirsten K. Ness, M. Beth McCarville and Michael D. Neel and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Michael W. Bishop

52 papers receiving 1.0k citations

Peers

Michael W. Bishop
Laura Johnston United States
Julio A. Díaz-Pérez United States
B. Fisher Canada
Charles A. Kunos United States
P. Koch Germany
Tae Hee Kim South Korea
Melinda S. Merchant United States
Laura Johnston United States
Michael W. Bishop
Citations per year, relative to Michael W. Bishop Michael W. Bishop (= 1×) peers Laura Johnston

Countries citing papers authored by Michael W. Bishop

Since Specialization
Citations

This map shows the geographic impact of Michael W. Bishop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Bishop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Bishop more than expected).

Fields of papers citing papers by Michael W. Bishop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Bishop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Bishop. The network helps show where Michael W. Bishop may publish in the future.

Co-authorship network of co-authors of Michael W. Bishop

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Bishop. A scholar is included among the top collaborators of Michael W. Bishop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Bishop. Michael W. Bishop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Shengjie, Yimei Li, Sue C. Kaste, et al.. (2025). Comparing Whole-Body Diffusion-weighted MRI to Conventional Imaging: Staging Pediatric Bone and Soft-Tissue Sarcomas. Radiology Imaging Cancer. 7(5). e240475–e240475.
2.
Bishop, Michael W.. (2025). Osteosarcoma. Hematology/Oncology Clinics of North America. 39(4). 749–760. 1 indexed citations
3.
Shulman, David S., Kelly Klega, Nan Chen, et al.. (2024). Prospective evaluation of pre-treatment ctDNA burden in localized osteosarcoma to identify patients with inferior outcomes: A report from the LEOPARD study.. Journal of Clinical Oncology. 42(16_suppl). 11510–11510. 1 indexed citations
4.
Mothi, Suraj Sarvode, Teresa Santiago, Dylan E. Graetz, et al.. (2024). Response of bilateral Wilms tumor to chemotherapy suggests histologic subtype and guides treatment. JNCI Journal of the National Cancer Institute. 116(8). 1230–1237.
6.
Bishop, Michael W., et al.. (2023). 18F-FDG PET/CT in the Management of Osteosarcoma. Journal of Nuclear Medicine. 64(6). 842–851. 17 indexed citations
7.
Mascarenhas, Leo, Chitose Ogawa, Theodore W. Laetsch, et al.. (2021). Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors. Cancer Medicine. 10(3). 843–856. 2 indexed citations
9.
Federico, Sara M., Alberto S. Pappo, Natasha Sahr, et al.. (2020). A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies. European Journal of Cancer. 137. 204–213. 44 indexed citations
10.
Roberts, Ryan D., Michael M. Lizardo, Damon R. Reed, et al.. (2019). Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group. Cancer. 125(20). 3514–3525. 87 indexed citations
11.
Stiles, Zachary E., Andrew J. Murphy, Doralina L. Anghelescu, et al.. (2019). Desmoplastic Small Round Cell Tumor: Long-Term Complications After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology. 27(1). 171–178. 21 indexed citations
12.
Lucas, John T., Israel Fernández‐Pineda, Christopher L. Tinkle, et al.. (2017). Late toxicity and outcomes following radiation therapy for chest wall sarcomas in pediatric patients. Practical Radiation Oncology. 7(6). 411–417. 14 indexed citations
13.
Liu, Wei, Michael W. Bishop, Alberto S. Pappo, et al.. (2017). Feasibility and Functional Outcomes of Children and Adolescents Undergoing Preoperative Chemotherapy Prior to a Limb-Sparing Procedure or Amputation. Rehabilitation Oncology. 35(1). 38–45. 26 indexed citations
14.
Fernández‐Pineda, Israel, Melissa M. Hudson, Alberto S. Pappo, et al.. (2016). Long-term functional outcomes and quality of life in adult survivors of childhood extremity sarcomas: a report from the St. Jude Lifetime Cohort Study. Journal of Cancer Survivorship. 11(1). 1–12. 51 indexed citations
15.
Interiano, Rodrigo B., Alpin D. Malkan, Amos Hong Pheng Loh, et al.. (2016). Initial diagnostic management of pediatric bone tumors. Journal of Pediatric Surgery. 51(6). 981–985. 10 indexed citations
16.
Hurley, Caitlin, M. Beth McCarville, Barry L. Shulkin, et al.. (2016). Comparison of 18 F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. Pediatric Blood & Cancer. 63(8). 1381–1386. 58 indexed citations
17.
Bishop, Michael W., et al.. (2015). Subsequent Neoplasms in Adult Survivors of Childhood Genitourinary Tumors. Urology. 86(4). 666–675.
18.
Bishop, Michael W., Katherine A. Janeway, & Richard Görlick. (2015). Future directions in the treatment of osteosarcoma. Current Opinion in Pediatrics. 28(1). 26–33. 214 indexed citations
19.
Loh, Amos Hong Pheng, Michael W. Bishop, Matthew J. Krasin, Andrew M. Davidoff, & Max R. Langham. (2014). Long-term physiologic and oncologic outcomes of inferior vena cava thrombosis in pediatric malignant abdominal tumors. Journal of Pediatric Surgery. 50(4). 550–555. 19 indexed citations
20.
Bishop, Michael W., Hong Yin, Hiroyuki Shimada, et al.. (2013). Management of Stage 4S Composite Neuroblastoma With a MYCN-amplified Nodule. Journal of Pediatric Hematology/Oncology. 36(1). e31–e35. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026